Signalling of Bruton's tyrosine kinase, Btk

Scandinavian Journal of Immunology

Volumn 49, Issue 2, 1999, Pages 113-118

  Mohamed, A J ^a,b,c   Nore, B F ^a,b   Christensson, B ^a   Smith, C I Edvard ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; LYMPHOCYTE RECEPTOR; PROTEIN TYROSINE KINASE;

ANTIBODY PRODUCTION; B LYMPHOCYTE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE MUTATION; HUMAN; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; HUMANS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; X CHROMOSOME;

EID: 0033013879     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00504.x     Document Type: Review

References (63)

1. Smith CIE, Bäckesjö CM, Berglöf A et al. X-linked agammaglobulinemia: Lack of mature B lineage cells caused by mutations in the Btk kinase. Springer Semin Immunopathol 1998;19:369-81.
2. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinemia is a member of the Src family of protein-tyrosine kinases. Nature 1993;361:226-33.
3. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-90.
4. Hendriks RW, de Bruijn MFTR, Maas A, Dingjan GM, Karis A, Grosveld F. Inactivation of Btk by insertion of lac Z reveals defects in B cell development past the pre-B cell stage. EMBO J 1996;15: 4862-72.
5. Vihinen M, Brandau O, Brandén L et al. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 1998;26:242-7.
6. Shaw G. The pleckstrin homology domain - an intriguing multifunctional protein module. Bioessays 1996;18:35-46.
7. Lemmon MA, Ferguson KM, Schlessinger J. PH domains: Diverse sequences with a common fold recruit signalling molecules to the cell surface. Cell 1996;85:621-4.
8. Vihinen M, Zvelebil MJJM, Zhu Q et al. Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia. Biochemistry 1995;34:1475-81.
9. Thomas DJ, Sideras P, Smith CI, Vorechovsky I, Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993;261:355-8.
10. Rawlings DJ, Saffran DC, Tsukada S et al. Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993;261:358-61.
11. Khan WN, Alt FW, Gerstein RM et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995;3:283-99.
12. Ochs HD, Smith CIE. X-linked agammaglobulinemia, a clinical and molecular analysis. Medicine 1996;75:287-99.
13. Burrows E, Cooper MD. B cell development and differentiation. Curr Opin Immunol 1997;9:239-44.
14. Tybulewicz VLJ. Analysis of antigen receptor signalling using mouse gene targeting. Curr Opin Cell Biol 1998;10:195-204.
15. Birkeland ML, Monroe JG. Biochemistry of antigen receptor signalling in mature and developing B lymphocytes. Crit Rev Immunol 1997;17:353-85.
16. Reth M, Wienands J. Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol 1997;15:453-79.
17. Kurosaki T. Molecular mechanisms in B cell antigen receptor signalling. Curr Opin Immunol 1997;9:309-18.
18. Qian D, Weiss A. T cell antigen receptor signal transduction. Curr Opin Cell Biol 1997;9:205-12.
19. Thomas S, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Biol 1997;13:513-609.
20. Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signalling. Cell 1997;90:293-301.
21. 2+ following B-cell receptor activation. EMBO J 1998;17:1973-85.
22. 3)/Tec kinase-dependent calcium signalling pathway: A target for SHIP-mediated inhibitory signals. EMBO J 1998;17:1961-72.
23. Desiderio S. Role of Btk in B cell development and signalling. Curr Opin Immunol 1997;9:534-40.
24. Hiles ID, Otsu M, Violinia S et al. Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit. Cell 1992;70:419-29.
25. Fukuda M, Kojima T, Kabayama H, Mikoshiba K. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J Biol Chem 1996;271:30303-6.
26. Salim K, Bottomley MJ, Querfurth E et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 1996;15:6241-50.
27. Rameh LE, Arvidsson AK, Carraway KL et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem 1997;272:22059-66.
28. Li T, Rawlings DJ, Park H, Kato RM, Witte ON, Satterthwaite A. Constitutive membrane association potentiates activation of Bruton's tyrosine kinase. Oncogene 1997;15:1375-83.
29. Li T, Tsukada S, Satterthwaite A et al. Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 1995;2:451-60.
30. Kurosaki T, Kurosaki M. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J Biol Chem 1997;272:15595-8.
31. Wahl MI, Fluckiger AC, Kato RM, Park H, Witte ON, Rawlings DJ. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc Natl Acad Sci USA 1997;94:11526-33.
32. Rawlings DJ, Scharenberg AM, Park H et al. Activation of Btk by a phosphorylation mechanism initiated by Src family kinases. Science 1996;271:822-5.
33. Hansson H, Mattsson PT, Allard P et al. Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 1998;37:2912-24.
34. Pawson T. Protein modules and signalling networks. Nature 1995;373:573-80.
35. Andreotti A, Stephen CB, Feng S, Berg LJ, Schreiber SL Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 1997;385:93-7.
36. cbl. Proteins Structure, Function and Genetics 1997:29:545-52.
37. Smith CIE, Islam KB, Vorechovsky I et al. X-linked agammaglobulinemia and other immunoglobin deficiencies. Immunol Rev 1994;138:159-83.
38. Roulier EM, Panzer S, Beckendorf SK. The Tec29 tyrosine kinase is required during Drosophila embryogenesis and interacts with Src64 in ring canal development. Mol Cell 1998;1:819-29.
39. Guarnieri DJ, Dodson GS, Simon MA. SRC64 regulates the localization of a Tec-family kinase required for Drosophila ring canal growth. Mol Cell 1998;1:831-40.
40. Li Z, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT, Witte ON. Phosphatidylinositol 3-kinase-γ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc Natl Acad Sci USA 1997;94:13820-5.
41. Takahasi-Tezuka M, Hibi M, Fujitani Y, Fukada T, Yamaguchi T, Hirano T. Tec tyrosine kinase links cytokine receptors to PI-3 kinase probably through JAK. Oncogene 1997;14:2273-82.
42. Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T. Tyrosine phosphorylation of Bruton's tyrosine kinase upon FcεRI cross-linking. Mol Cell Biol 1994;14:5108-13.
43. Burgering BMT, Coffer PJ. Protein kinase B (C-AKT) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995;376:599-602.
44. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998;10:262-7.
45. Tsukada S, Simon M, Witte ON, Katz A. Binding of the βγ subunits of heterotrimeric G-proteins to the PH domain of Bruton's tyrosine kinase. Proc Natl Acad Sci USA 1994;91:11256-60.
46. Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton's tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 1994;91:9175-9.
47. Yang W, Desiderio S. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagment. Proc Natl Acad Sci USA 1997;94:604-9.
48. Cory GOC, Lovering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinsky RJ, Kinnon C. The protein product of the c-cbl proto-oncogene is phosphorylated after B cedll receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med 1995;182:611-15.
49. Yang W, Malek SN, Desiderio S. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J Biol Chem 1995;270:20832-40.
50. Matsushita M, Yamadori T, Kato S et al. Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (Btk). Biochem Biophys Res Commun 1998;245:337-43.
51. Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol Cell Biol 1995;15:5304-11.
52. Afar DEH, Park H, Howell BW, Rawlings DJ, Cooper J, Witte ON. Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol 1996;16:3465-71.
53. August A, Sadra A, Dupont B, Hanafusa H. Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the pleckstrin homology domain of inducible T cell kinase. Proc Natl Acad Sci USA 1997;94:11227-32.
54. Kitanaka A, Kiroyuki M, Conley ME, Campana D. Expression and activation of the non-receptor tyrosine kinase Tec in human B cells. Blood 1998;91:940-8.
55. Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998;8:509-16.
56. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J Exp Med 1996;184:31-40.
57. Kristupaitis D, Dibirdik I, Vassilev A et al. Electormagnetic field-induced stimulation of Bruton's tyrosine kinase. J Biol Chem 1998;273:12397-401.
58. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998;74:49-139.
59. Hata D, Kitaura J, Hartman Se Kawakami Y, Yokota T, Kawakami T. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. J Biol Chem 1998;273:10979-87.
60. Hata D, Kawakami Y, Inagaki N et al. Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998;187:1235-47.
61. Goodman PA, Niehoff LB, Uckun FM. Role of tyrosine kinase in induction of the c-jun proto-oncogene in irradiated B-lineage cells. J Biol Chem 1998;273:17742-8.
62. Teramoto H, Salem P, Robbins KC, Bustelo XR, Gutkind JS. Tyrosine phosphorylation of the var proto-oncogene product links FcεRI to the Racl-JNK pathway. J Biol Chem 1997;272:10751-5.
63. Deng J, Kawakami Y, Hartman SE, Satoh T, Kawakami T. Involvement of Ras in Bruton's tyrosine kinase-mediated JNK activation. J Biol Chem 1998;273:16787-91.